Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis

Kim, Donghee, Kim, Won, Joo, Sae Kyung, Bae, Jeong Mo, Kim, Jung Ho, Ahmed, Aijaz·2018·Clinical Gastroenterology and Hepatology
DOI 10.1016/j.cgh.2017.08.014

Cited by (191)

Items 101–191 of 191

  1. Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
    Eddison Godinez Leiva, Fernando Bril · 2020 · Current Hypertension Reviews
  2. Longitudinal Change in Thyroid-Stimulating Hormone and Risk of Nonalcoholic Fatty Liver Disease
    Goh Eun Chung, Donghee Kim, Min‐Sun Kwak, Jeong Yoon Yim, Aijaz Ahmed, Joo Sung Kim · 2020 · Clinical Gastroenterology and Hepatology
  3. Liver fibrotic burden across the spectrum of hypothyroidism
    Tingting Du, Yuchai Huang, Yongman Lv, Gang Yuan · 2024 · Journal of Gastroenterology
  4. Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis
    Amalia Gastaldelli, Egeria Scoditti, Maria Paula Macedo · 2026 · Diabetologia
  5. Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
    Alba Martínez-Escudé, Guillem Pera, Lluís Rodríguez, Íngrid Arteaga, Carmen Expósito-Martínez, Pere Torán‐Monserrat, Llorenç Caballería · 2021 · Journal of Clinical Medicine
  6. Vitamin D alleviates hypothyroidism associated liver dysfunction: Histological and biochemical evidence
    Seyed Hamidreza Rastegar-Moghaddam, Mahsan Akbarian, Arezoo Rajabian, Fatemeh Alipour, Alireza Ebrahimzadeh‐Bideskan, Mahmoud Hosseini · 2023 · Heliyon
  7. A preliminary study: proteomic analysis of exosomes derived from thyroid-stimulating hormone-stimulated HepG2 cells
    Shizhan Ma, Shanshan Shao, Chongbo Yang, Zhenyu Yao, Ling Gao, Weixian Chen · 2020 · Journal of Endocrinological Investigation
  8. Joint Analysis of Genetic Correlation, Mendelian Randomization and Colocalization Highlights the Bi-Directional Causal Association Between Hypothyroidism and Primary Biliary Cirrhosis
    Yanjun Wang, Ping Guo, Yanan Zhang, Lu Liu, Ran Yan, Zhongshang Yuan, Yongfeng Song · 2021 · Frontiers in Genetics
  9. Resmetirom: Finally, the Light at the End of the NASH Tunnel?
    Amedeo Lonardo · 2024 · Livers
  10. Association of Sensitivity to Thyroid Hormones and Non-Alcoholic Fatty Liver Disease and the Severity of Liver Fibrosis in Euthyroid Adults: A Retrospective Study
    Liyuan Zhou, Lanxuan Jiang, Yu An, Jia Liu, Guang Wang, Ying Wang, Ning Yang · 2025 · Diabetes Metabolic Syndrome and Obesity
  11. Low-free triiodothyronine is associated with poor prognosis of portal hypertension in cirrhosis
    Xiaoquan Huang, Siyu Jiang, Xiaowen Fan, Yingyi Jiang, Ling Wu, Feng Li, Jian Wang, Shiyao Chen · 2019 · European Journal of Gastroenterology & Hepatology
  12. Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry
    Amon Asgharpour, Amreen M. Dinani, Scott L. Friedman · 2020 · Translational Gastroenterology and Hepatology
  13. Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis
    Divya Shekhar Shetty, Anjali Deepak Amarapurkar, Akash Shukla · 2020 · Journal of Clinical and Experimental Hepatology
  14. Nonalcoholic Steatohepatitis in Children
    Stavra A. Xanthakos · 2022 · Clinics in Liver Disease
  15. Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome
    Bernardo Gindri dos Santos, Niki F. Brisnovali, Leigh Goedeke · 2024 · Biochemical Journal
  16. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis
    Chaoqun Li, Chunshan Zhao, Zihan Yu, Wanting Yang, Mingyu Sun, Yifan Li, Gaoyue Guo, Yangyang Hui, Xiaoyu Wang, Xiaofei Fan et al. · 2022 · Postgraduate Medicine
  17. Thyroid hormone: a resurgent treatment for an emergent concern
    Mason Breitzig, Matthew D. Alleyn, Richard F. Lockey, Narasaiah Kolliputi · 2018 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  18. Abnormal and Euthyroid Ranges of Thyroid Hormones in Serum and Liver Cancer Mortality: A Cohort Study
    Won Sohn, Yoosoo Chang, Yong Kyun Cho, Yejin Kim, Ho Cheol Shin, Seungho Ryu · 2020 · Cancer Epidemiology Biomarkers & Prevention
  19. Severe hypothyroidism-associated acute renal failure – A case series from North India and review of literature
    Abhilash Chandra, NamrataS Rao, Kiranpreet Malhotra · 2019 · Thyroid Research and Practice
  20. Evaluation of thyroid function and thyroid autoimmune disease in patients with non-alcoholic fatty liver disease
    Rania Naguib, Amel Ahmed Fayed, Eman Elkemary, Hend Naguib · 2021 · Clinical and Experimental Hepatology
  21. ECM remodeling in hypothyroidism-associated MAFLD: mechanisms, clinical relevance, and therapeutic targets
    Tianzhen Wang, Liyun Duan, Beiying Zhao, Jingbin Zhang, Yongjiang Yu, Jin-Yue Zhao · 2025 · Frontiers in Immunology
  22. Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease
    Xinrui Jin, Sherlot Juan Song, Jimmy Che‐To Lai, Grace Lai‐Hung Wong, Alice P.S. Kong, Nana Peng, Xiang Xiao, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip · 2025 · Clinical and Molecular Hepatology
  23. A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy
    Monan Liu, Ye Ma, Wai San Cheang, Zhengding Su, Suowen Xu · 2026 · Molecular Therapy
  24. Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
    Tetiana Ranhulova · 2021 · Galician Medical Journal
  25. Cardiometabolic risk profiles in subclinical hypothyroidism, and the potential impact of statin therapy: A cross-sectional and longitudinal study
    Dimitrios Tsilingiris, Theodora Stratigou, Dimitrios Kounatidis, Natalia G. Vallianou, Ιrene Karampela, Μaria Dalamaga · 2025 · Metabolism Open
  26. Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients: a retrospective cohort study
    Zixuan Li, Xiaoying Wu, Zebin Chen, Xiuqing Wei, Weiqing Chen · 2023 · Gastroenterology report
  27. Extrahepatic manifestations of metabolic dysfunction-associated steatotic liver disease: An updated clinical overview
    Chia-Hsun Tsai, Tsung‐Hsing Hung, Tuck-Siu Wong, Chung-Yi Lin, Chia-Lu Hsu, Ping‐Hung Ko, Yi-Chun Chou, Hsing-Feng Li, Sou‐Hsin Chien, Ching‐Sheng Hsu · 2025 · Tzu Chi Medical Journal
  28. Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
    Jörn Markus Schattenberg, Pierre Bédossa, Cynthia D. Guy, Rebecca A. Taub, Dominic Labriola, Hang Zhang, James K. Hennan, Raul C. Camacho, Elaine Chng, Yayun Ren et al. · 2026 · Journal of Hepatology
  29. Analysis of epidemiological association patterns of serum thyrotropin by combining random forests and Bayesian networks
    Ann‐Kristin Becker, Till Ittermann, Marcus Dörr, Stephan Burkhard Felix, Matthias A. Nauck, Alexander Teumer, Uwe Völker, Henry Völzke, Lars Kaderali, Neetika Nath · 2022 · PLoS ONE
  30. One Case of Pituitary Stalk Interruption Syndrome Associated with Liver Cirrhosis
    Dong Mei Li, Huan He · 2023 · Endocrine Metabolic & Immune Disorders - Drug Targets
  31. Impact of peripheral thyroid hormone balance on liver fat: insights from the NutriAct trial
    Miriam Sommer, Thu-Huong Nguyen, Laura Pletsch‐Borba, Charlotte Wernicke, Frank Tacke, Tanja Schwerdtle, Denny Pellowski, Jürgen Machann, Joachim Spranger, Eva Katrin Wirth et al. · 2024 · European Journal of Endocrinology
  32. Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies
    Alessandro Mantovani, Giorgio Grani · 2018 · Digestive Diseases and Sciences
  33. Investigation of the effect of hyperthyroidism on endoplasmic reticulum stress and tran- sient receptor potential canonical 1 channel in the kidney
    Ezgi Bektur, Erhan Şahin, Sedat Kaçar, Rıdvan Bağcı, Şerife Karakaya, Dilek Burukoğlu Dönmez, Varol Şahıntürk · 2021 · TURKISH JOURNAL OF MEDICAL SCIENCES
  34. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease
    Xinhe Zhang, Haoyu Tian, Yiling Li · 2022 · iLiver
  35. Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones
    Qiuhong Liu, Han Li, Weiwei He, Qing Chuan Zhao, Caoxin Huang, Qingxuan Wang, Zeyu Zheng, Xiaofang Zhang, Xiulin Shi, Xuejun Li · 2022 · Frontiers in Endocrinology
  36. The protective effect of hesperidin on the liver of hypothyroid rats mediated by nuclear factor erythroid 2-related factor 2-dependent activation of heme oxygenase 1
    Walaa Hegazy, Adel Abdel‐Moneim, Eman S. Abdel-Rehiem, Marwa Salah, Manal Abdul‐Hamid · 2022 · Journal of Molecular Histology
  37. Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease
    Zheng Wang, H Wang, Hui Sun · 2025 · Physiological Research
  38. Discovery of the Insecticide Chlorantraniliprole as a Thyroid Hormone Receptor β Antagonist Reinforcing Thyroid-Liver Metabolic Disruption to Promote Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ling Jiao, Yi Yang, Yixuan Huang, Hailin Shang, Zehua Liu, Wenyi Li, Jinqi Sun, Hui Yang, Jianying Hu, Yi Wan · 2025 · Environmental Science & Technology
  39. Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends
    George Sarin Zacharia, Muhammad H Ashraf, Franklin Sosa, Anu Jacob, Harish Patel · 2025 · World Journal of Gastrointestinal Pharmacology and Therapeutics
  40. The thyroid-liver axis in MASLD: From metabolic control to clinical translation
    Yasmina Chouik, Cyrielle Caussy, Frank Tacke · 2026 · Med
  41. Thyroid‐Liver Axis: The Role of Thyroid Dysfunction in the Pathogenesis and Progression of MASLD: A Comprehensive Review
    Stefania Capuccio, G. Privitera, Sabrina Scilletta, F. La Rocca, Maurizio Di Marco, R. Scicali, A. Di Pino, S. Piro, M. Russello · 2026 · Liver international (Print)
  42. Impaired sensitivity to thyroid hormone is associated with developing non-alcoholic fatty liver disease in euthyroid diabetic subjects
    Xiaowen Zhang, Jie Liu, Qian Wang, Han Chen, Yu Yan, Xinyue Xiang, Shanmei Shen, Wenhuan Feng · 2024 · Frontiers in Endocrinology
  43. Grape Seed Proanthocyanidin Alleviates Oxidative Stress and Apoptosis Involved in Liver of Hyperthyroid Mice
    Maha Abdulrahman Aldubayan · 2019 · Annual Research & Review in Biology
  44. Ameliorative Effects of Thunbergia erecta L. Leaves Against the Initiation of Hepatocarcinogenesis Induced by Diethylnitrosamine in the Rat Model
    Fatma Sayed Abdel-Aal Farag, Hend Mohamed Anwar, Tarek Aboushousha, Hala Sh. Mohammed, Lotfi Diab Mousa Ismail · 2023 · Applied Biochemistry and Biotechnology
  45. Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine
    Roberta Pujia, Elisa Mazza, Tiziana Montalcini, Franco Arturi, Antonio Brunetti, Antônio Aversa, Stefano Romeo, Maria Perticone, Angela Sciacqua, Arturo Pujia · 2022 · Medicina
  46. Improving NASH with a little help from thyromimetics
    Vlad Ratziu · 2019 · The Lancet
  47. Hepatic Transcriptomic Patterns in the Neonatal Rat After Pentabromodiphenyl Ether Exposure
    June K. Dunnick, Keith R. Shockley, Daniel L. Morgan, Gregory S. Travlos, Kevin Gerrish, Thai-Vu T. Ton, Ralph Wilson, Sukhdev S. Brar, Amy E. Brix, Suramya Waidyanatha A et al. · 2019 · Toxicologic Pathology
  48. Hypothyroidism phenotypes, clinical characteristics, and factors associated with nodular thyroid disease in patients with hypothyroidism in Southern Ghana: a 6-year retrospective study
    Samuel Ametepe, Brian Yaw Entsiey Nyarko, Isaac Wormekpor, Bright Kantah, Michael Appiah, Precious Kwablah Kwadzokpui, Esther Ngozi Adejumo, Christian Obirikorang, Abigail Ibrahim, Belinda Ampomah Kwarteng et al. · 2025 · BMC Endocrine Disorders
  49. Association Between Subclinical Hypothyroidism and MASLD: A Systematic Review and Meta‐Analysis
    Gedion Yilma Amdetsion, Chun‐Wei Pan, Hiwot Gebeyehu Tebeje, Abhin Sapkota, Shreyas Raghavan Nandyal, Vikram S. Kotwal · 2025 · International Journal of Hepatology
  50. Pharmacology of NASH
    Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2021 · Elsevier eBooks
  51. The Oxidoreductase Retinol Saturase in Thyroid Gland Is Regulated by Hypothyroidism and Iodide Overload and Its Deletion Impairs Metabolic Homeostasis in Mice
    Na Young Yang, Lisa Wessoly, Yueming Meng, Marie F. Kiefer, Yingfu Chen, Madita Vahrenbrink, Sascha Wulff, Chen Li, Jonah W. Schreier, Julia S. Steinhoff et al. · 2024 · Antioxidants and Redox Signaling
  52. Predictive value of thyroid-stimulating hormone in postmenopausal type 2 diabetes mellitus patients with normal thyroid function associated with ultrasound-diagnosed non-alcoholic fatty liver disease
    Yijun Du, Tianrong Pan, Xing Zhong, Nina Liu, Qiu Zhang · 2022 · All Life
  53. Factors affecting blood pressure in patients with arterial hypertension and subclinical hypothyroidism
    Anastasiia O. Radchenko, Olena Vadymivna Kolesnikova · 2021 · Arterial Hypertension
  54. Subclinical Thyroid Dysfunction and Cardiovascular Disease
    Inês Lourenço, Joana Correia-Chaves, Ana Rita Leite, Marta Borges‐Canha, Madalena von Hafe, Catarina Vale, Adelino Ferreira Leite-Moreira, João Sérgio Neves · 2023 · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
  55. Recent advances in anterior pituitary hormones and metabolic-associated fatty liver disease
    Changqing Liu, Yuanyuan Long, Junjun Liu, Yongfeng Song · 2025 · Frontiers in Endocrinology
  56. Dysregulation of hepatic deiodinase type I in metabolically associated steatotic liver disease
    Nuria López‐Alcántara, Alison-Michelle Naujack, Yingfu Chen, Natalie Taege, Cathleen Geißler, Rebecca Oelkrug, Eva Katrin Wirth, Lutz Schomburg, Anita Boelen, Henriette Kirchner et al. · 2025 · Journal of Molecular Endocrinology
  57. Impaired Thyroid Hormone Sensitivity is Associated with Increased Risk of Liver Fibrosis in Euthyroid Population: A Cross-Sectional Analysis of NHANES
    Xingyu Yao, Kaiwen Xiao, Hein Ko Oo · 2025 · Hormone and Metabolic Research
  58. Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model
    Samantha Maurotti, Bernadette Scopacasa, Francesca Scionti, Roberta Pujia, Miriam Frosina, Angela Mirarchi, Nadia Geirola, Rosario Mare, Tiziana Montalcini, Patrizio Candeloro et al. · 2025 · Molecular and Cellular Endocrinology
  59. Association Between Thyroid Hormone Sensitivity Indicators and Controlled Attenuation Parameter (CAP) Values in Euthyroid Adults with Overweight/Obesity
    Yifang Zhang, Cuiping Bao, Lingling Liu, Renjiao Liu, Xincheng Wang, X H Guo, Chunjun LI · 2026 · Diabetes Metabolic Syndrome and Obesity
  60. Research status and progress of metabolic associated fatty liver disease
    Zhao-Chun Chi · 2022 · World Chinese Journal of Digestology
  61. mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma
    Marina Serra, Rajesh Ramavadh Pal, Elisabetta Puliga, Pia Sulas, Lavinia Cabras, Roberto Cusano, Silvia Giordano, Andrea Perra, Amedeo Columbano, Marta Anna Kowalik · 2022 · Frontiers in Oncology
  62. Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease
    Ping Li, Liang Liu, Bin Niu, Yuqiang Mi, Yonggang Liu, Jing Feng, Peng Zhang, Xue Wu, Weike Chu · 2022 · Medicine
  63. Relationship between impaired sensitivity to thyroid hormones and MAFLD with elevated liver enzymes in the euthyroid population
    Haixia Zeng, Jianping Liu, Yuying Zhang · 2024 · International Journal of Diabetes in Developing Countries
  64. Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review
    Han Yu, Zhijun Wang, Gang Zhao · 2024 · Pharmacognosy Magazine
  65. Association between hypothyroidism and metabolic dysfunction-associated steatohepatitis in adults with obesity without diabetes
    Sasha D. Macedo-Lozano, Maria A. Garcia-Aguilar, Gustavo Salinas-Sedo, Kennlly Cardoza-Jiménez, Wah Yang, Ming‐Hua Zheng, Carlos Jesus Toro-Huamanchumo · 2025 · Obesity Medicine
  66. Diabetes: Insights into Thyroid Hormones
    Shahid Shehzad, Muhammad Naeem, Rasif Khan, Rashed Ali Khan, Saqibah Rehman, Rida Naz · 2022 · Pakistan Journal of Medical and Health Sciences
  67. Hígado graso: Epidemiología, diagnóstico y tratamiento
    Martín Tagle · 2022 · Diagnóstico
  68. The Endocrinology of Liver Disease
    Jacob George, Mohammed Eslam · 2022
  69. Low nanomolar Triiodothyronine Concentrations Drive Further Maturation of hiPSC-Derived Hepatocyte-Like Cells
    Joshua Seifert, Katarzyna Anna Ludwik, Valeria Beatriz Fernández Vallone, Nicolai von Kügelgen, Regina Jahn, Josef Köhrle, Harald Stachelscheid, Eva Katrin Wirth · 2025 · Research Square
  70. Primary (Postoperative) Hypothyroidism and Non-Alcoholic Fatty Liver Disease in Women
    S.V. Shchelochenkov, G.S. Dzhulay · 2019 · Effective Pharmacotherapy
  71. FT3 to FT4 Ratio is Associated with Non-Alcoholic Steatohepatitis and Significant Fibrosis in Euthyroid Subjects with NAFLD
    Haibo Xue, Yaqi Guan, Juzeng Zheng, Ziqiang Xia, Ye Li, Jinming Wu · 2020
  72. Hypothyroidism and Non-Alcoholic Fatty Liver Disease
    Randa Hazam, Ahmed Taha, John Kimbugwe, Nahla Elzubeir, Sameer Prakash, Faiza Mubeen, Bharat Khandheria · 2020 · Journal of Endocrinology and Metabolism
  73. Association of TSH Levels in the Therapeutically Neglected Range of 6.5–8 mIU/L with Significant Changes in Liver and Kidney Function: A Retrospective Study of the Kashmiri Population
    Tousief Irshad Ahmed, Ruqaya Aziz · 2022 · Sudan Journal of Medical Sciences
  74. Subclinical hypothyroidism: Let the evidence be your guide
    Nicholas M. LeFevre · 2023 · The Journal of Family Practice
  75. Endocrinopathies in Nonalcoholic Fatty Liver Disease
    Ana-Maria Sîngeap, Laura Huiban · 2023 · Springer eBooks
  76. Nonalcoholic fatty liver disease: What comes before and what are the consequences?
    Fernando Bril · 2024 · Elsevier eBooks
  77. Association between the Thyroid Hormone Levels and Metabolic Associated Fatty Liver Disease in Type 2 Diabetes Mellitus Egyptian Patients
    Abdel-Naser Abdel-Atty Gadallah, Ahmed Abu sheneb, Ashraf Gharieb Dala, Mohamed El-Hosiny El-Sayed Esawy, Mohamed Zakarya Nooh · 2024 · Surgery Gastroenterology and Oncology
  78. Metabolic comorbidities, endocrine—Diabetes, polycystic ovarian syndrome, thyroid dysfunction
    Rui‐Xu Yang, Jian‐Gao Fan · 2024 · Elsevier eBooks
  79. Use of transient elastography for hepatic steatosis and fibrosis evaluation in patients with subclinical hypothyroidism
    Milena Tauil Auad Noronha Santos, Cristiane Alves Villela‐Nogueira, Nathalie Carvalho Leite, Patrícia de Fátima dos Santos Teixeira, Marcus Vinícius Leitão de Souza · 2024 · Archives of Endocrinology and Metabolism
  80. Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom
    Sadatsugu Sakane, Hayato Hikita · 2025 · Journal of Gastroenterology
  81. Thyroid function and hepatic fibrosis/cirrhosis: a two-sample Mendelian randomization study
    Yan Wang, Xiaoli Zhang, Qin Li, Qing Zhang, Jun Liu · 2025 · Frontiers in Genetics
  82. Research Advances in the Correlation between Hypothyroidism and Metabolic Associated Fatty Liver Disease
    羽 龙 · 2025 · Advances in Clinical Medicine
  83. Molecular Pathways Linking Thyroid Dysfunction, NT-proBNP, and Cardiac Health: A Clinical and Biomarker-based Analysis
    Jayesh Prabhakar Warade, Sunil A Chakole · 2025 · Indian Journal of Medical Biochemistry
  84. The impact of hypothyroidism on the risk of intrahepatic cholestasis of pregnancy: a large-scale study based on pregnant women with hypothyroidism in Shanghai, China
    Mu Lv, Zhijuan Cao, Chuanlu Xu, Xiaoxian Qu, Yirong Bao, Ling Yuan, Hao Ying · 2026 · Journal of Global Health
  85. Masks of postoperative hypothyroidism
    E. V. Treneva, О В Косарева, S. V. Bulgakova, Dmitrii P. Kurmaev, Lyudmila A. Sharonova, Yu. A. Dolgikh, P. Ya. Merzlova, A. S. Mikhailova · 2025 · Экспериментальная и клиническая гастроэнтерология
  86. Correlation Between the Thyroid Hormone Levels and Type 2 Diabetes Mellitus in Non-Alcoholic Fatty Liver Disease
    Liya Bian, Hua Fan, Qingwen Yu, Xiyun Rao, Ting Tang, Lanlan Feng, Yongmin Shi, Xuhan Tong, Xingwei Zhang, Jiake Tang et al. · 2026 · Diabetes Metabolic Syndrome and Obesity
  87. The role of thyroid status in modulating the level of neuroregulin-4 (NRG4) in non-alcoholic fatty liver disease
    Natalia Prokhorova, Dmitrii V. Ovchinnikov, Ruslan Ivanovich Glushakov · 2026 · Meditsinskiy sovet = Medical Council
  88. Association between overt, subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging
    Amany Sholkamy, Ahmed El-Meligui, Eman Hassan Ahmed Ibrahim Saad, Samar Amin, mirette makram, Noha Elmansy, Shrook Mousa · 2026 · World Journal of Hepatology
  89. Prevalence of Subclinical Hypothyroidism and Its Association with Noninvasive Fibrosis Scores in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Aysun Seker · 2026 · OSMANGAZİ JOURNAL OF MEDICINE
  90. Clonal hematopoiesis of indeterminate potential and metabolic dysfunction-associated steatotic liver disease: Korean biopsy cohort
    Yun Kyu Lee, Hyungtai Sim, Sae Kyung Joo, Heejoon Jang, Dong Hyeon Lee, Jeong Hwan Park, Keon Wook Kang, Murim Choi, Won Kyum Kim · 2026 · Hepatology International
  91. HOMA-IR and hypothyroidism interact to predict liver fibrosis in MASLD: a hypothesis-generating finding
    Sayfullo Avezov, Mirkhozhi Khuzhamurotov · 2026 · Clinics and Research in Hepatology and Gastroenterology